Dramatic clinical response following dabrafenib and trametinib therapy in a heavily pretreated low grade serous ovarian carcinoma patient with a BRAF V600E mutation

• Main Authors: Alberto A. Mendivil (Author), Paul K. Tung (Author), Randy Bohart (Author), Karen Bechtol (Author), Bram H. Goldstein (Author)
• 格式: 图书
• 出版: Elsevier, 2018-11-01T00:00:00Z.
• 主题: article
• 在线阅读: Connect to this object online.

Low grade serous ovarian cancer (LGSOC) is a slowly growing, relatively chemoresistant neoplasm that is associated with a more favorable prognosis, especially compared to the disease's high-grade serous counterpart. We recount a case involving a 47-year-old, heavily pretreated LGSOC patient who...